PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 20260 citationsOpen Access

Visible Spectrophotometric Estimation of Amprenavir in Pharmaceutical Formulations

View Full Paper
NRNakka Raju*1, P. Raveendra Reddy2, P.Janaki Pathi3, N. Appala Raju4

Key Points

  • To develop simple methods for estimating amprenavir in pharmaceutical formulations.
  • Developed two spectrophotometric methods (A and B) for analysis of amprenavir.
  • Method A uses Folin–Ciocalteu reagent reaction to form a colored chromogen at 715 nm.
  • Method B uses PDAC with sulfuric acid to create a colored chromogen at 505 nm.
  • Both methods validated through statistical and recovery studies.
  • Method A shows linear absorbance over 50-500 μg/mL, while Method B ranges from 10-100 μg/mL.
  • Proposed methods are economical and sensitive for estimating amprenavir in bulk drugs and formulations.

Abstract

Two simple, accurate, rapid and sensitive methods (A and B) have been developed for the estimation of Amprenavir in its pharmaceutical dosage form. The Method A is based on the formation of bluish-green colored chromogen, due to reaction of Amprenavir with Folin–Ciocalteu reagent (FCR) reagent in the presence of alkaline medium, which exhibits λ max at 715 nm. Method B is based on the reaction of Amprenavir with PDAC in the presence of Sulfuric acid to form a red colored chromogen, which shows maximum absorbance at 505 nm. The absorbance-concentration plot is linear over the range of 50-500 μg/mL for Method A, 10-100 μg/mL for Method B. Results of analysis for all the methods were validated statistically and by recovery studies. Literature survey reveals only HPLC methods deals with biological fluids and in fixed pharmaceutical dosage forms. The proposed methods are economical and sensitive for the estimation of Amprenavir in bulk drug and in its formulations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nakka Raju*1, P. Raveendra Reddy2, P.Janaki Pathi3, N. Appala Raju4 (2026) studied this question.

synapsesocial.com/papers/69faa2e204f884e66b5337behttps://doi.org/10.5281/zenodo.20021644
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and Validation of UV Spectroscopic method for the estimation of favipiravir in bulk and tablet dosage form2024
  2. 2Development and validation of UV-spectrophotometry method for quantitative determination of amorphous darunavir2024
  3. 3Eco‐Friendly Analytical Approaches for the Quantification of Molnupiravir and Favipiravir Using Capillary Zone Electrophoresis and Derivative Ratio Spectrophotometry2024 · 6 citations
  4. 4Development of eco-friendly and sustainable analytical methods for Ritonavir through white analytical chemistry and AQbD approach2026 · 2 citations
  5. 5Spectrophotometric Determination, Analysis And Validation Of Acyclovir 0n Solid Dosage Form2024